Edwards Lifesciences Corp.

Company Overview

Edwards Lifesciences Corp. provides medical technologies for treating critical conditions, vascular diseases, and structural heart disorders. It offers a wide range of products across three main groups: transcatheter aortic valve replacement, transcatheter mitral and tricuspid therapies, and surgical structural heart. It specializes in developing advanced heart valve systems used in both surgical and transcatheter procedures for heart valve replacement and repair. Additionally, it offers a range of surgical heart valve and repair solutions, as well as minimally invasive hemodynamic monitoring systems, pressure-monitoring devices, hemofiltration technologies, and vascular stents.

Edward's transcatheter and surgical heart valve therapy products are manufactured in the U.S., Singapore, and Switzerland. Its critical care products are manufactured in its facilities in Puerto Rico and the Dominican Republic.

Financial Highlights (FY 2025)

Company's Business Segments

• Transcatheter Aortic Valve Replacement : Transcatheter heart valve replacement technologies are designed for the minimally invasive replacement of Aortic heart valves.
• Transcatheter Mitral and Tricuspid Therapies : The development of transcatheter heart valve repair and replacement technologies designed to treat Mitral, Tricuspid valve diseases.
• Surgical Structural Heart : This segment includes innovations for cardiac surgery patients, products like RESILIA tissue, INSPIRIS RESILIA aortic valve, KONECT RESILIA which has VFit technology first pre-assembled, ready-to-implant, tissue valved conduit for complex combined procedures.
• Critical Care : This segment includes advanced Hemodynamic monitoring systems used to measure a patient's heart function and fluid status in surgical and intensive care settings. Edwards’ complete hemodynamic portfolio helps clinicians make proactive clinical decisions that can improve patient recovery. The portfolio includes the minimally-invasive FloTrac and Acumen IQ sensors, the noninvasive ClearSight, Acumen IQ cuffs, and the ForeSight noninvasive tissue oximetry sensor.